Ameliorating cerebral hypoperfusion after traumatic brain injury.
DeWitt
D S
DS
Prough
D S
DS
D000818:Animals; D001120:Arginine / Q000627:therapeutic use*; D001783:Blood Flow Velocity / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001930:Brain Injuries / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D002545:Brain Ischemia / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D002540:Cerebral Cortex / Q000293:injuries*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D010656:Phenylephrine / Q000627:therapeutic use*; D011379:Prognosis; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D010656:Phenylephrine; D001120:Arginine